₹ 622.25
Key Takeaways
Risk factor
Limited trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Weak growth
Data is available to registered users only
Data is available to registered users only
About
Aarti Pharmalabs Limited, headquartered in Mumbai, India, is engaged in the manufacturing and commercialization of a diverse range of pharmaceutical substances across India. Its offerings encompass active pharmaceutical ingredients (APIs), pharmaceutical intermediates, new chemical entities, and xanthine derivatives. The firm, which commenced operations in 2019, was formerly known as Aarti Organics Limited.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Data is available to registered users only